Our scaling up operations through strategic manufacturing expansion into APIs, tablets, capsules, and syrups, backed by significant investments in advanced machinery and sustainable technologies.
Set up manufacturing units to manufacture intermediate products, APIs, tablets &capsules ,dry syrups and liquid syrups.
Invest in advanced machinery and sustainable technologies.
Develop and introduce new products solutions tailored to market needs.
Launch targeted marketing initiatives to raise brand awareness and attract new clients.
Increase market share by targeting mid-sized and large pharmaceutical companies.
Expand marketing network to cover additional regions.
Form strategic alliances with key players in the pharmaceutical industry.
The company secures long-term B2B contracts with healthcare institutions, pharmacies, and wholesalers to maintain steady demand and bulk pricing. Additional revenue growth is continually captured by expanding its product portfolio with new pharmaceutical offerings tailored to market trends.
Revenue is primarily generated from the manufacturing and distribution of high quality Intermediates , Active Pharmaceutical Ingredients and medicines under Orgoras Healthcare Brand.
Offering specialized packaging and labeling services to clients, ensuring compliance with regulatory standards, and creating an additional revenue stream.
Income is derived from long-term contracts with healthcare institutions, pharmacies, and wholesalers, providing consistent demand and bulk order pricing.
Revenue growth through the introduction of new pharmaceutical products in response to market demands and emerging healthcare trends.
All Rights Reserved – copyright © 2026